Vivoryon Therapeutics AG

10/08/2019 | Press release | Distributed by Public on 10/08/2019 06:29

Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments